Bruck Kifle

Array ( [id] => 990804 [patent_doc_number] => 06919331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-19 [patent_title] => 'Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents' [patent_app_type] => utility [patent_app_number] => 10/309505 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40981 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/919/06919331.pdf [firstpage_image] =>[orig_patent_app_number] => 10309505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660247 [patent_doc_number] => 20030134891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'New D-proline prodrugs' [patent_app_type] => new [patent_app_number] => 10/307699 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7095 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134891.pdf [firstpage_image] =>[orig_patent_app_number] => 10307699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843697 [patent_doc_number] => 20030149044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Succinic acid salts of 5,7,14-triazatetracyclo[10.1.02.11.04,9] -hexadeca-1(11),3,5,7,9-pentaene and pharmaceutical compositions thereof' [patent_app_type] => new [patent_app_number] => 10/305845 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3735 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20030149044.pdf [firstpage_image] =>[orig_patent_app_number] => 10305845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1050141 [patent_doc_number] => 06861420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-01 [patent_title] => 'N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds' [patent_app_type] => utility [patent_app_number] => 10/305408 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14099 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/861/06861420.pdf [firstpage_image] =>[orig_patent_app_number] => 10305408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660239 [patent_doc_number] => 20030134883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => '14-Methyl-epothilones' [patent_app_type] => new [patent_app_number] => 10/304315 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19712 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134883.pdf [firstpage_image] =>[orig_patent_app_number] => 10304315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805410 [patent_doc_number] => 20030232804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Glycinamides as factor Xa inhibitors' [patent_app_type] => new [patent_app_number] => 10/304070 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61478 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232804.pdf [firstpage_image] =>[orig_patent_app_number] => 10304070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 620251 [patent_doc_number] => 07141668 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-28 [patent_title] => 'Process for recovering caprolactam' [patent_app_type] => utility [patent_app_number] => 10/495862 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3320 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/141/07141668.pdf [firstpage_image] =>[orig_patent_app_number] => 10495862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7449333 [patent_doc_number] => 20040009969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Piperazine derivatives that destabilize androgen receptors' [patent_app_type] => new [patent_app_number] => 10/301871 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40457 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009969.pdf [firstpage_image] =>[orig_patent_app_number] => 10301871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788201 [patent_doc_number] => 20030139440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Deuterated rapamycin compounds, method and uses thereof' [patent_app_type] => new [patent_app_number] => 10/300015 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3538 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139440.pdf [firstpage_image] =>[orig_patent_app_number] => 10300015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 951374 [patent_doc_number] => 06960578 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-01 [patent_title] => 'Glutamate receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/300449 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41412 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/960/06960578.pdf [firstpage_image] =>[orig_patent_app_number] => 10300449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1224161 [patent_doc_number] => 06699876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-02 [patent_title] => 'Camptothecin analogue compounds' [patent_app_type] => B2 [patent_app_number] => 10/300330 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9380 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 577 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699876.pdf [firstpage_image] =>[orig_patent_app_number] => 10300330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6707016 [patent_doc_number] => 20030153750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Thienodibenzoazulene compounds as tumor necrosis factor inhibitors' [patent_app_type] => new [patent_app_number] => 10/298217 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18230 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153750.pdf [firstpage_image] =>[orig_patent_app_number] => 10298217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1216826 [patent_doc_number] => 06706727 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-16 [patent_title] => 'Macrolides' [patent_app_type] => B1 [patent_app_number] => 10/276622 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4535 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706727.pdf [firstpage_image] =>[orig_patent_app_number] => 10276622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697324 [patent_doc_number] => 20030109518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Substituted 1,4-benzodiazepines and uses thereof' [patent_app_type] => new [patent_app_number] => 10/292876 [patent_app_country] => US [patent_app_date] => 2002-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39358 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109518.pdf [firstpage_image] =>[orig_patent_app_number] => 10292876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1156332 [patent_doc_number] => 06765005 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-20 [patent_title] => 'Fab I inhibitors' [patent_app_type] => B2 [patent_app_number] => 10/292687 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11425 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/765/06765005.pdf [firstpage_image] =>[orig_patent_app_number] => 10292687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5895454 [patent_doc_number] => 20060003993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Benzotriazepnes as gastrin and cholecystokinin receptor ligands' [patent_app_type] => utility [patent_app_number] => 10/495464 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59912 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003993.pdf [firstpage_image] =>[orig_patent_app_number] => 10495464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852065 [patent_doc_number] => 20030144268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors' [patent_app_type] => new [patent_app_number] => 10/291978 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9080 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144268.pdf [firstpage_image] =>[orig_patent_app_number] => 10291978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7368278 [patent_doc_number] => 20040092561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Azolidinone-vinyl fused -benzene derivatives' [patent_app_type] => new [patent_app_number] => 10/289998 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14637 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092561.pdf [firstpage_image] =>[orig_patent_app_number] => 10289998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697330 [patent_doc_number] => 20030109524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/289055 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19375 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109524.pdf [firstpage_image] =>[orig_patent_app_number] => 10289055 [rel_patent_id] =>[rel_patent_doc_number] =>)